Aster DM Healthcare and Quality Care India Ltd (QCIL) has announced plans to invest ₹1,661 crore in Kerala to expand healthcare infrastructure by adding 1,315 new hospital beds in the coming years.
Addressing reporters after meeting the Chief Minister V. D. Satheesan, Azad Moopen said Aster alone will add 834 beds in the State, including a new 454-bed hospital in Thiruvananthapuram, aimed at strengthening access to advanced healthcare services in South Kerala.
With the planned expansion, the combined network will operate 11 hospitals across Kerala with a total capacity of 4,575 beds, creating one of the country’s strongest healthcare networks and enhancing the availability of tertiary and quaternary care services, he said.
The group currently employs more than 18,400 healthcare professionals and expects to generate nearly 7,900 additional jobs through the expansion, contributing significantly to both healthcare capacity and economic growth in the State.
Moopen discussed with the Chief Minister about the opportunities to further strengthen healthcare infrastructure, medical education, skill development, employment generation, healthcare technology, medical tourism and charitable initiatives.
“Kerala occupies a special place in Aster’s journey and continues to be one of our most strategic markets. The State’s highly skilled doctors, nurses and allied healthcare professionals are respected across India and globally. We remain committed to partnering with Kerala in its vision of becoming one of India’s leading healthcare destinations,” he said.
Moopen also highlighted Aster’s ₹120-crore Cancer Care CSR Programme, under which advanced cancer treatment facilities will be established across different parts of India over the next three years.
The first project under the initiative will be the installation of a state-of-the-art Linear Accelerator (LINAC) facility in Wayanad, bringing advanced radiation therapy closer to patients in underserved regions. The project is expected to benefit thousands of cancer patients who currently face financial and geographical barriers in accessing treatment.